VA SB642

Requires health insurers and HMOs to allow patients to have cancer and blood disease medications dispensed by their in-network treating provider rather than a designated specialty pharmacy

Permits in-network providers to dispense provider-administered cancer drugs when there is a documented delay of at least three days from the specialty pharmacy

Allows patients to have self-administered cancer and blood disease medications sent to the pharmacy of their choosing

Coverage includes FDA-approved cancer treatments and supportive therapies such as anti-emetics, antibiotics, and pain medications to address treatment side effects

Prohibits insurers and pharmacy benefits managers from penalizing or retaliating against providers or pharmacies for exercising rights under this section, though prior authorization and step-therapy requirements remain permitted